17 U.S. lawmakers have disclosed 57 Regeneron Pharmaceuticals, Inc. trades under the STOCK Act — 38 buys and 19 sells between 2013 and 2026. Congress has been net buyers of REGN, and their disclosed buys are down 2.0% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of REGN, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed REGN buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-27 | Alan Armstrong | BUY | $1K–$15K | $737.71 | $805.97 2026-08-13 | +9.3% |
| 2025-04-10 | Byron Donalds | SELL | $1K–$15K | $546.39 | $805.97 2026-08-13 | -0.8% rt |
| 2024-11-13 | Jonathan Jackson | SELL | $15K–$50K | $804.33 | $805.97 2026-08-13 | -13.4% rt |
| 2024-11-01 | Jonathan Jackson | SELL | $1K–$15K | $843.60 | $805.97 2026-08-13 | +8.2% rt |
| 2024-10-15 | Greg Landsman | SELL | $1K–$15K | $1016.53 | $805.97 2026-08-13 | +20.7% exit |
| 2024-04-04 | Thomas H Tuberville | SELL | $1K–$15K | $937.02 | $805.97 2026-08-13 | +13.4% rt |
| 2024-01-17 | Jonathan Jackson | BUY | $1K–$15K | $929.13 | $805.97 2026-08-13 | -13.3% |
| 2023-06-23 | Jonathan Jackson | BUY | $15K–$50K | $779.73 | $805.97 2026-08-13 | +3.4% |
| 2023-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $826.19 | $805.97 2026-08-13 | -2.5% |
| 2023-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $826.19 | $805.97 2026-08-13 | -2.5% |
| 2022-10-19 | Josh Gottheimer | BUY | $1K–$15K | $709.37 | $805.97 2026-08-13 | +13.6% |
| 2022-09-12 | Josh Gottheimer | BUY | $1K–$15K | $710.74 | $805.97 2026-08-13 | +13.4% |
| 2022-05-05 | Josh Gottheimer | BUY | $1K–$15K | $639.37 | $805.97 2026-08-13 | +26.1% |
| 2022-03-30 | Thomas H Tuberville | SELL | $1K–$15K | $692.38 | $805.97 2026-08-13 | +43.8% rt |
| 2021-10-05 | Byron Donalds | BUY | $1K–$15K | $550.90 | $805.97 2026-08-13 | +46.3% |
| 2021-09-17 | Donald Sternoff Honorable Beyer Jr | BUY | $1K–$15K | $651.88 | $805.97 2026-08-13 | +23.6% |
| 2021-07-21 | Donald Sternoff Honorable Beyer Jr | BUY | $1K–$15K | $583.72 | $805.97 2026-08-13 | +38.1% |
| 2021-07-01 | Josh Gottheimer | SELL | $1K–$15K | $574.62 | $805.97 2026-08-13 | +14.3% rt |
| 2021-06-17 | Donald Sternoff Honorable Beyer Jr | BUY | $1K–$15K | $536.01 | $805.97 2026-08-13 | +50.4% |
| 2021-05-17 | Josh Gottheimer | SELL | $1K–$15K | $523.73 | $805.97 2026-08-13 | -3.7% rt |
| 2021-03-29 | Thomas H Tuberville | BUY | $1K–$15K | $481.52 | $805.97 2026-08-13 | +67.4% |
| 2021-01-11 | Josh Gottheimer | BUY | $1K–$15K | $502.92 | $805.97 2026-08-13 | +60.3% |
| 2020-12-11 | Josh Gottheimer | SELL | $1K–$15K | $479.77 | $805.97 2026-08-13 | +54.5% rt |
| 2020-08-14 | Donald Sternoff Beyer Jr | SELL | $1K–$15K | $612.57 | $805.97 2026-08-13 | -31.6% exit |
| 2020-05-27 | Josh Gottheimer | BUY | $1K–$15K | $544.01 | $805.97 2026-08-13 | +48.1% |
| 2020-05-13 | Dean Phillips | SELL | $1K–$15K | $577.12 | $805.97 2026-08-13 | +103.7% rt |
| 2020-01-15 | Mikie Sherrill | BUY | $1K–$15K | $390.75 | $805.97 2026-08-13 | +106.3% |
| 2019-12-12 | Mikie Sherrill | SELL | $1K–$15K | $372.16 | $805.97 2026-08-13 | -116.6% exit |
| 2019-11-01 | Josh Gottheimer | BUY | $1K–$15K | $310.48 | $805.97 2026-08-13 | +159.6% |
| 2019-09-20 | Josh Gottheimer | SELL | $1K–$15K | $295.87 | $805.97 2026-08-13 | -172.4% exit |
| 2019-09-11 | Dean Phillips | BUY | $1K–$15K | $283.33 | $805.97 2026-08-13 | +184.5% |
| 2018-09-18 | Gary Palmer | SELL | $1K–$15K | $388.33 | $805.97 2026-08-13 | -107.5% exit |
| 2017-12-18 | Sheldon Whitehouse | SELL | $15K–$50K | $383.39 | $805.97 2026-08-13 | -3.6% rt |
| 2017-11-22 | Peter Welch | BUY | $1K–$15K | $387.54 | $805.97 2026-08-13 | +108.0% |
| 2017-11-20 | Peter Welch | BUY | $1K–$15K | $385.22 | $805.97 2026-08-13 | +109.2% |
| 2017-11-08 | Peter Welch | BUY | $1K–$15K | $415.17 | $805.97 2026-08-13 | +94.1% |
| 2017-11-07 | Peter Welch | BUY | $1K–$15K | $404.39 | $805.97 2026-08-13 | +99.3% |
| 2017-11-06 | Peter Welch | BUY | $1K–$15K | $406.63 | $805.97 2026-08-13 | +98.2% |
| 2017-11-03 | Peter Welch | BUY | $1K–$15K | $408.41 | $805.97 2026-08-13 | +97.3% |
| 2017-05-16 | Sheldon Whitehouse | BUY | $1K–$15K | $454.75 | $805.97 2026-08-13 | +77.2% |
| 2016-09-06 | Sheldon Whitehouse | BUY | $1K–$15K | $398.31 | $805.97 2026-08-13 | +102.3% |
| 2016-09-06 | Sheldon Whitehouse | BUY | $1K–$15K | $398.31 | $805.97 2026-08-13 | +102.3% |
| 2016-05-24 | Sheldon Whitehouse | BUY | $1K–$15K | $397.70 | $805.97 2026-08-13 | +102.7% |
| 2016-02-26 | K. Michael Conaway | SELL | $1K–$15K | $394.23 | $805.97 2026-08-13 | -104.4% exit |
| 2016-01-29 | James B. Renacci | BUY | $1K–$15K | $420.09 | $805.97 2026-08-13 | +91.9% |
| 2016-01-28 | James B. Renacci | BUY | $1K–$15K | $415.11 | $805.97 2026-08-13 | +94.2% |
| 2016-01-28 | K. Michael Conaway | SELL | $1K–$15K | $415.11 | $805.97 2026-08-13 | -94.2% exit |
| 2016-01-27 | James B. Renacci | BUY | $1K–$15K | $434.16 | $805.97 2026-08-13 | +85.6% |
| 2015-12-07 | James B. Renacci | BUY | $1K–$15K | $546.61 | $805.97 2026-08-13 | +47.5% |
| 2015-09-30 | James B. Renacci | BUY | $1K–$15K | $465.14 | $805.97 2026-08-13 | +73.3% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
17 members of the U.S. House and Senate have disclosed Regeneron Pharmaceuticals, Inc. transactions under the STOCK Act — 38 purchases and 19 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a REGN purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed REGN buys are down 2.0% versus the latest close of $805.97. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded REGN and how it performed.